Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.

PMID:31762217
Zhang RZ , Ma TX , Qi DW , Zhao M , Hu T , Zhang GC
Orthopaedic surgery
The purpose of this retrospective study was to evaluate the clinical and oncological results of combination treatment of short-term preoperative denosumab (the receptor activator of nuclear factor kappa-B ligand inhibitor) with surgery in unresectable or recurrent cases of giant cell tumor of the bone (GCTB).


Copyright(C) 2006 BIOIMPACT Co., Ltd. All Rights Reserved